UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

BMC medicine, 2018-02, Vol.16 (1), p.31-31, Article 31

2018

Volltextzugriff (PDF)

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

BMC medicine, 2020-05, Vol.18 (1), p.114-114, Article 114

2020

Volltextzugriff (PDF)

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer

Scientific reports, 2017-07, Vol.7 (1), p.5554-12, Article 5554

2017

Volltextzugriff (PDF)

Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathways

Clinical radiology, 2019-11, Vol.74 (11), p.894.e1-894.e9

2019

Volltextzugriff (PDF)

Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer

British journal of cancer, 2013-02, Vol.108 (3), p.597-601

2013

Volltextzugriff (PDF)

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

British journal of cancer, 2014-05, Vol.110 (10), p.2405-2411

2014

Volltextzugriff (PDF)

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

EBioMedicine, 2015-09, Vol.2 (9), p.1133-1144

2015

Volltextzugriff (PDF)

Changing presentation of prostate cancer in a UK population ― 10 year trends in prostate cancer risk profiles in the East of England

British journal of cancer, 2013-10, Vol.109 (8), p.2115-2120

2013

Volltextzugriff (PDF)

The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population

Scientific reports, 2016-10, Vol.6 (1), p.35364, Article 35364

2016

Volltextzugriff (PDF)

Hydrogen production from coal using coal direct chemical looping and syngas chemical looping combustion systems: Assessment of system operation and resource requirements

International journal of hydrogen energy, 2009-03, Vol.34 (6), p.2606-2615

2009

Volltextzugriff (PDF)

Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method

Journal of clinical urology, 2018-05, Vol.11 (3), p.192-199

2018

Volltextzugriff (PDF)

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer

The Journal of pathology, 2007-09, Vol.213 (1), p.82-90

2007

Volltextzugriff (PDF)

Novel three-dimensional bone 'mapping' software can help assess progression of osseous metastases from routine CT

Radiation oncology (London, England), 2017-08, Vol.12 (1), p.143-143, Article 143

2017

Volltextzugriff (PDF)

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines

British journal of cancer, 2012-01, Vol.106 (3), p.436-439

2012

Volltextzugriff (PDF)

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

British journal of cancer, 2001-12, Vol.85 (12), p.1928-1936

2001

Volltextzugriff (PDF)

A comparison of operative and margin outcomes from surgeon learning curves in robot assisted radical prostatectomy in a changing referral practice

Annals of the Royal College of Surgeons of England, 2018-03, Vol.100 (3), p.226-229

2018

Volltextzugriff (PDF)

Men’s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study

Cancer causes & control, 2021-03, Vol.32 (3), p.261-269

2021

Volltextzugriff (PDF)

DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: A feasibility study

Magnetic resonance in medicine, 2012-03, Vol.67 (3), p.778-785

2012

Volltextzugriff (PDF)

Primary Radical Therapy Selection in High-risk Non-metastatic Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-03, Vol.27 (3), p.136-144

2015

Volltextzugriff (PDF)

Hydrogen production from coal gasification for effective downstream CO2 capture

International journal of hydrogen energy, 2010-05, Vol.35 (10), p.4933-4943

2010

Volltextzugriff (PDF)

Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer

Journal of cancer research and clinical oncology, 2011-02, Vol.137 (2), p.235-241

2011

Volltextzugriff (PDF)

Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150]

Molecular and cellular endocrinology, 2017-03, Vol.443, p.175-175

2017

Volltextzugriff (PDF)

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease

British journal of cancer, 2009-12, Vol.101 (11), p.1891-1899

2009

Volltextzugriff (PDF)

Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer

Human pathology, 2008-08, Vol.39 (8), p.1197-1204

2008

Volltextzugriff (PDF)

Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development

Oncogene, 2003-04, Vol.22 (16), p.2466-2477

2003

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(135)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer

Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathways

Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

Changing presentation of prostate cancer in a UK population ― 10 year trends in prostate cancer risk profiles in the East of England

The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population

Hydrogen production from coal using coal direct chemical looping and syngas chemical looping combustion systems: Assessment of system operation and resource requirements

Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer

Novel three-dimensional bone 'mapping' software can help assess progression of osseous metastases from routine CT

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

A comparison of operative and margin outcomes from surgeon learning curves in robot assisted radical prostatectomy in a changing referral practice

Men’s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study

DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: A feasibility study

Primary Radical Therapy Selection in High-risk Non-metastatic Prostate Cancer

Hydrogen production from coal gasification for effective downstream CO2 capture

Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer

Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150]

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease

Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer

Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development

Suchergebnisse filtern